SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

NBIS is trending due to recent dilution news and a $3 billion Meta AI infrastructure deal, leading to mixed community sentiment. While some investors express concerns about short-term impacts and potential overvaluation, others emphasize the long-term growth potential and strong partnerships with major tech companies. The community is actively debating the significance of the dilution and its effect on future stock performance.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave ($CRWV) is trending downwards as the community discusses a significant drop following earnings, despite a double beat and strong backlog, with concerns focusing on a cut in forward guidance and potential data center delays. Community members are debating whether this is a buying opportunity or a sign of deeper issues with the company's business model and debt. Some speculate on a potential AI bubble, while others point to long-term contracts and strong demand as reasons for optimism.

Leifras Co., Ltd. Engages in sport training, event and alliance & club activity support and healthcare activities. It provides services related to the organization and operations of sports schools and sports events for children and it also operate a robust social business sector, dispatching sports coaches to meet various community needs. The company was founded by Kiyotaka Ito on August 28, 2001 and is headquartered in Tokyo, Japan.

Leifras Co Ltd - ADR

LEIFRAS Co., Ltd. American Depositary Shares

LFS is trending due to a recent surge, with community members actively discussing its potential as a low-float runner and comparing it to similar IPOs. The stock's volatility and after-hours movement have captured attention, although some traders caution about potential pump-and-dump dynamics. The company's recent contract award and financials are also circulating as potential catalysts.

Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.

Anavex Life Sciences Corporation

Anavex Life Sciences Corp

AVXL is trending as investors closely monitor discussions surrounding its Alzheimer's drug, Blarcamesine, with community debates focusing on potential approval outcomes and the significance of an oral explanation from the EMA. Concerns over market manipulation and short selling are prevalent, while some investors express confidence based on the drug's safety profile and potential benefits, leading to speculation about a possible short squeeze.

Galecto, Inc. is a clinical-stage biotechnology company, which engages in developing novel small molecule therapeutics that are designed to target the biological processes that lie at the heart of cancer and fibrotic diseases. The firm is also involved in the development of small molecule inhibitors of galectin-3 and LOXL2. The company was founded by Ulf Jörgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsgård Schambye in 2011 and is headquartered in Boston, MA.

Galecto Inc

GLTO is trending due to significant price movement and high trading volume, sparking discussions around a potential short squeeze. Community members are actively debating entry and exit points, while some highlight the company's cash position and potential for further gains. The stock's volatility and recent news have drawn attention, with comparisons being made to other low-float runners.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer ($PFE) is trending as investors discuss its potential acquisition of Metsera amidst a bidding war with Novo Nordisk, with community chatter focusing on whether Pfizer is overpaying and the implications for its pipeline. Some are speculating on a potential bidding war for Viking Therapeutics should Pfizer lose out. The stock's high trading volume and upcoming dividend are also contributing to the buzz.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending amid speculation of a potential bidding war and buyout offers, fueled by competitor Metsera's recent acquisition. Community chatter revolves around potential suitors, including non-pharma companies, and the possibility of a short squeeze. Some traders suggest the market is undervaluing VKTX given its promising pipeline and potential in the obesity and metabolic disorder space.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor ($OPEN) is trending due to speculation of a potential short squeeze, supported by bullish technical indicators. Community members are pointing to warrant distributions and reported insider buying as potential catalysts. Some traders are also excited about the company's new CEO and AI-driven turnaround strategy.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is trending due to a mix of factors, including impressive Q3 revenue growth and a delayed Neutron launch, which has sparked debate about the company's future timeline and valuation; the community is actively discussing whether the delay is already priced in, and if the company can meet its ambitious targets. Bullish investors point to strong fundamentals and potential government contracts, while bears express concern about valuation and profitability, creating a split in sentiment.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


68gamebai33comx5

Nhà Đài 68gamebai